These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8612737)

  • 1. A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression of R2 cDNA.
    Fan H; Villegas C; Wright JA
    FEBS Lett; 1996 Mar; 382(1-2):145-8. PubMed ID: 8612737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.
    Fan H; Villegas C; Wright JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14036-40. PubMed ID: 8943056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
    Hurta RA; Wright JA
    Biochem Cell Biol; 1991 Sep; 69(9):635-42. PubMed ID: 1793565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian drug resistant mutants with multiple gene amplifications: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin.
    Hurta RA; Wright JA
    Biochim Biophys Acta; 1990 Oct; 1087(2):165-72. PubMed ID: 2223878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence of a mosquito ribonucleotide reductase cDNA and evidence for gene amplification in hydroxyurea-resistant cells.
    Shotkoski FA; Jayachandran G; Stamatoyannopoulos G; Fallon AM
    Insect Mol Biol; 1999 Nov; 8(4):565-70. PubMed ID: 10620053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ferritin gene expression is associated with increased ribonucleotide reductase gene expression and the establishment of hydroxyurea resistance in mammalian cells.
    McClarty GA; Chan AK; Choy BK; Wright JA
    J Biol Chem; 1990 May; 265(13):7539-47. PubMed ID: 2185252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
    Amara FM; Hurta RA; Huang A; Wright JA
    Cancer Res; 1995 Oct; 55(20):4503-6. PubMed ID: 7553616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1998 Apr; 58(8):1650-3. PubMed ID: 9563477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.
    Hurta RA; Wright JA
    J Biol Chem; 1992 Apr; 267(10):7066-71. PubMed ID: 1551913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
    Chitambar CR; Wereley JP
    Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.
    Amara FM; Chen FY; Wright JA
    Nucleic Acids Res; 1993 Oct; 21(20):4803-9. PubMed ID: 8233829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the M2 subunit of ribonucleotide reductase in regulation by hydroxyurea of the activity of the anti-HIV-1 agent 2',3'-dideoxyinosine.
    Gao WY; Zhou BS; Johns DG; Mitsuya H; Yen Y
    Biochem Pharmacol; 1998 Jul; 56(1):105-12. PubMed ID: 9698094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.
    Wright JA; Chan AK; Choy BK; Hurta RA; McClarty GA; Tagger AY
    Biochem Cell Biol; 1990 Dec; 68(12):1364-71. PubMed ID: 2085432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of ribonucleotide reductase from Chlamydia trachomatis.
    Roshick C; Iliffe-Lee ER; McClarty G
    J Biol Chem; 2000 Dec; 275(48):38111-9. PubMed ID: 10984489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric small subunit inhibitors of mammalian ribonucleotide reductase: a dual function for the R2 C-terminus?
    Hamann CS; Lentainge S; Li LS; Salem JS; Yang FD; Cooperman BS
    Protein Eng; 1998 Mar; 11(3):219-24. PubMed ID: 9613846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
    Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
    Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.